Entering text into the input field will update the search result below

Can-Fite Biopharma GAAP EPS of -$0.01, revenue of $0.74M

Mar. 28, 2024 7:20 AM ETCan-Fite BioPharma Ltd. (CANF) StockBy: Deepa Sarvaiya, SA News Editor
  • Can-Fite Biopharma press release (NYSE:CANF): FY GAAP EPS of -$0.01.
  • Revenue of $0.74M (-8.6% Y/Y).

Recommended For You

More Trending News

About CANF Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CANF--
Can-Fite BioPharma Ltd.